These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 30078207)
1. First-In-Human Administration of Allogeneic Amnion Cells in Premature Infants With Bronchopulmonary Dysplasia: A Safety Study. Lim R; Malhotra A; Tan J; Chan ST; Lau S; Zhu D; Mockler JC; Wallace EM Stem Cells Transl Med; 2018 Sep; 7(9):628-635. PubMed ID: 30078207 [TBL] [Abstract][Full Text] [Related]
2. Human amnion cells for the prevention of bronchopulmonary dysplasia: a protocol for a phase I dose escalation study. Baker EK; Malhotra A; Lim R; Jacobs SE; Hooper SB; Davis PG; Wallace EM BMJ Open; 2019 Mar; 9(2):e026265. PubMed ID: 30826799 [TBL] [Abstract][Full Text] [Related]
3. Allogeneic human umbilical cord-derived mesenchymal stem cells for severe bronchopulmonary dysplasia in children: study protocol for a randomized controlled trial (MSC-BPD trial). Wu X; Xia Y; Zhou O; Song Y; Zhang X; Tian D; Li Q; Shu C; Liu E; Yuan X; He L; Liu C; Li J; Liang X; Yang K; Fu Z; Zou L; Bao L; Dai J Trials; 2020 Jan; 21(1):125. PubMed ID: 32005282 [TBL] [Abstract][Full Text] [Related]
4. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia. Bassler D Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104 [TBL] [Abstract][Full Text] [Related]
5. Two-year outcomes of infants enrolled in the first-in-human study of amnion cells for bronchopulmonary dysplasia. Malhotra A; Lim R; Mockler JC; Wallace EM Stem Cells Transl Med; 2020 Mar; 9(3):289-294. PubMed ID: 31774236 [TBL] [Abstract][Full Text] [Related]
6. Human amnion cells reverse acute and chronic pulmonary damage in experimental neonatal lung injury. Zhu D; Tan J; Maleken AS; Muljadi R; Chan ST; Lau SN; Elgass K; Leaw B; Mockler J; Chambers D; Leeman KT; Kim CF; Wallace EM; Lim R Stem Cell Res Ther; 2017 Nov; 8(1):257. PubMed ID: 29126435 [TBL] [Abstract][Full Text] [Related]
7. Stem cell therapy for bronchopulmonary dysplasia: bench to bedside translation. Ahn SY; Chang YS; Park WS J Korean Med Sci; 2015 May; 30(5):509-13. PubMed ID: 25931779 [TBL] [Abstract][Full Text] [Related]
8. Preterm human amnion epithelial cells have limited reparative potential. Lim R; Chan ST; Tan JL; Mockler JC; Murphy SV; Wallace EM Placenta; 2013 Jun; 34(6):486-92. PubMed ID: 23597502 [TBL] [Abstract][Full Text] [Related]
9. Off-label mesenchymal stromal cell treatment in two infants with severe bronchopulmonary dysplasia: clinical course and biomarkers profile. Álvarez-Fuente M; Arruza L; Lopez-Ortego P; Moreno L; Ramírez-Orellana M; Labrandero C; González Á; Melen G; Cerro MJD Cytotherapy; 2018 Nov; 20(11):1337-1344. PubMed ID: 30327248 [TBL] [Abstract][Full Text] [Related]